NCT04833725

Screening and Early Warning of Chronic Obstructive Pulmonary Disease Combined With Sleep Respiratory Disease Based on Medical Internet of Things

Status unknown Last updated 6 April 2021

What this trial tests

trial testing wearable devices in COPD in 680 participants. Status unknown.

Timeline

1 January 2020

Primary endpoint
31 December 2021

31 December 2022

Quick facts

Lead sponsor	Peking University Third Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	680
Start date	1 January 2020
Primary completion	31 December 2021
Estimated completion	31 December 2022
Sites	1 location across China

Drugs / interventions tested

• wearable devices

Conditions studied

• COPD — all drugs for COPD →
• Osa Syndrome — all drugs for Osa Syndrome →

Sponsor

Peking University Third Hospital

Who can join

Adults 40 to 80, any sex, with COPD or Osa Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Chronic obstructive pulmonary disease (COPD) is a common disease that endangers people's health, causing severe economic and treatment burdens. Sleep breathing disease, as a complication of COPD, increases the hospitalization rate and mortality of COPD. At present, community doctors have insufficient knowledge of COPD and its complications, and they also lack standardized screening and related disease management capabilities. This trail intends to use IoT medical technology to screen for COPD combined with sleep breathing diseases. It can establish a two-way referral channel between primary community hospitals and higher-level hospitals, which provides early warning services for COPD combined with sleep breathing diseases. This trial explores the impact of sleep breathing disease on COPD's acute exacerbation, which improves the understanding of COPD patients combined with sleep breathing diseases. It also improves COPD management and its complications control at the community-level and reduces COPD patients' potential risks and treatment burdens. It also explores tiered diagnosis and treatment models for COPD, promotes the construction of intelligent IoT infrastructure, and enhances standardized diagnosis and treatment of COPD at the grassroots level in China.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Screening and early warning system for chronic obstructive pulmonary disease with obstructive sleep apnoea based on the medical Internet of Things in three levels of healthcare: protocol for a prospective, multicentre, observational cohort study.
   Pan Z, Liao S, Sun W, Zhou H, et al · · 2024 · cited 2× · PMID 38418236 · DOI 10.1136/bmjopen-2023-075257